Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat

KEY CLINICAL MESSAGE: This is the first case report of treatment with toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS. This reported case highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS. ABSTRACT: Feline r...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Hiroyuki, Ueshima, Asuka, Kobayashi, Yoshitaka, Shimoyama, Yumiko, Takiyama, Naoaki, Rimpo, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276202/
https://www.ncbi.nlm.nih.gov/pubmed/37334334
http://dx.doi.org/10.1002/ccr3.7582
_version_ 1785060026330644480
author Komatsu, Hiroyuki
Ueshima, Asuka
Kobayashi, Yoshitaka
Shimoyama, Yumiko
Takiyama, Naoaki
Rimpo, Kenji
author_facet Komatsu, Hiroyuki
Ueshima, Asuka
Kobayashi, Yoshitaka
Shimoyama, Yumiko
Takiyama, Naoaki
Rimpo, Kenji
author_sort Komatsu, Hiroyuki
collection PubMed
description KEY CLINICAL MESSAGE: This is the first case report of treatment with toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS. This reported case highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS. ABSTRACT: Feline restrictive orbital myofibroblastic sarcoma (FROMS) is a rare aggressive tumor in cats. We explored the effectiveness of using toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS in a 7‐year‐old cat. Despite treatment, the cat died 4 months after surgery. This report highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS.
format Online
Article
Text
id pubmed-10276202
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102762022023-06-18 Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat Komatsu, Hiroyuki Ueshima, Asuka Kobayashi, Yoshitaka Shimoyama, Yumiko Takiyama, Naoaki Rimpo, Kenji Clin Case Rep Case Report KEY CLINICAL MESSAGE: This is the first case report of treatment with toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS. This reported case highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS. ABSTRACT: Feline restrictive orbital myofibroblastic sarcoma (FROMS) is a rare aggressive tumor in cats. We explored the effectiveness of using toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS in a 7‐year‐old cat. Despite treatment, the cat died 4 months after surgery. This report highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS. John Wiley and Sons Inc. 2023-06-17 /pmc/articles/PMC10276202/ /pubmed/37334334 http://dx.doi.org/10.1002/ccr3.7582 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Komatsu, Hiroyuki
Ueshima, Asuka
Kobayashi, Yoshitaka
Shimoyama, Yumiko
Takiyama, Naoaki
Rimpo, Kenji
Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title_full Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title_fullStr Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title_full_unstemmed Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title_short Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
title_sort feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (palladia) as adjuvant chemotherapy: a case study of one cat
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276202/
https://www.ncbi.nlm.nih.gov/pubmed/37334334
http://dx.doi.org/10.1002/ccr3.7582
work_keys_str_mv AT komatsuhiroyuki felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat
AT ueshimaasuka felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat
AT kobayashiyoshitaka felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat
AT shimoyamayumiko felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat
AT takiyamanaoaki felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat
AT rimpokenji felinerestrictiveorbitalmyofibroblasticsarcomatreatedwithtoceranibphosphatepalladiaasadjuvantchemotherapyacasestudyofonecat

Ejemplares similares